CLOV:NSD-Clover Health Investments Corp (USD)

COMMON STOCK | Healthcare Plans |

Last Closing

USD 3.17

Change

+0.03 (+0.96)%

Market Cap

USD 1.81B

Volume

5.10M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-06-02 )

Largest Industry Peers for Healthcare Plans

Symbol Name Price(Change) Market Cap
ALHC Alignment Healthcare LLC

-0.17 (-1.10%)

USD 3.12B
MRAI Marpai Inc

-0.01 (-0.71%)

USD 0.02B

ETFs Containing CLOV

N/A

Market Performance

  Market Performance vs. Industry/Classification (Healthcare Plans) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 0.63% 33% F 63% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 0.63% 33% F 62% D
Trailing 12 Months  
Capital Gain 170.94% 100% F 96% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 170.94% 100% F 96% N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 26.56% 100% F 82% B
Dividend Return 26.56% 100% F 82% B
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 138.73% 33% F 14% F
Risk Adjusted Return 19.14% 100% F 57% F
Market Capitalization 1.81B 67% D+ 79% B-

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.